Literature DB >> 1593848

Elevation of albumin synthesis rates in nephrotic patients measured with [1-13C]leucine.

P E Ballmer1, B K Weber, P Roy-Chaudhury, M A McNurlan, H Watson, D A Power, P J Garlick.   

Abstract

Eight patients with a nephrotic syndrome and a histologically-proven kidney disease were compared to age- and sex-matched healthy volunteers. Albumin synthesis rates were measured after injection of 13C-labelled leucine (57 mg/kg body wt, 19.4 atoms%). Plasma volume was determined with 125I-albumin. The fractional synthesis rate of albumin was 7.9 +/- 0.4%/day in control subjects in comparison with a marked elevation to 18.4 +/- 2.0%/day (P less than 0.001) in nephrotic patients. The absolute synthesis rate was 145 +/- 9 mg/kg/day in control subjects compared with 213 +/- 17 mg/kg/day (P = 0.005) in the nephrotic patients. There was a statistically significant correlation between ASR and urinary albumin loss (P = 0.035) and serum cholesterol concentration (P = 0.007). The calculated oncotic pressure was significantly lower in the nephrotic group than in the controls (P less than 0.001), but was without correlation with ASR.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593848     DOI: 10.1038/ki.1992.17

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

1.  Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans.

Authors:  P E Ballmer; M A McNurlan; H N Hulter; S E Anderson; P J Garlick; R Krapf
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 2.  Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.

Authors:  David G Levitt; Michael D Levitt
Journal:  Int J Gen Med       Date:  2016-07-15

3.  Clinical value of serum cholinesterase levels in Nephrotic syndrome: an observational study.

Authors:  Kimihiko Goto; Keiji Kono; Hideki Fujii; Shunsuke Goto; Shinichi Nishi
Journal:  BMC Nephrol       Date:  2022-04-02       Impact factor: 2.388

4.  Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool.

Authors:  B K Ballmer-Weber; R Dummer; E Küng; G Burg; P E Ballmer
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.